Back
Ryman Healthcare 10K Form
Sell
31
RHCGF
Ryman Healthcare
Last Price:
2.61
Seasonality Move:
-18.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RHCGF News And Ratings
See the #1 stock for the next 7 days that we like better than RHCGF
RHCGF Financial Statistics
Sales & Book Value
Annual Sales: | $350.71M |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $4.17 |
Price / Book: | 0 |
Profitability
EPS (TTM): | 0.79380 |
---|---|
Net Income (TTM): | $396.81M |
Gross Margin: | $350.71M |
Return on Equity: | 0% |
Return on Assets: | 0% |
Ryman Healthcare Earnings Forecast
Key Ryman Healthcare Financial Ratios
- The Gross Profit Margin over the past 20 years for RHCGF is 100.00%.
- The Selling, General & Administrative Expenses for RHCGF have been equal to 60.70% of Gross Profit Margin.
- The Interest Expense is 4.40% of Operating Income.
- The Net Earning history of RHCGF is 137.54% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 17 years.
Ryman Healthcare Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Health Care Providers & Services |
Sector: | Health Care |
Current Symbol: | RHCGF |
Website: | rymanhealthcare.co.nz |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
RHCGF Technical Analysis vs Fundamental Analysis
Sell
31
Ryman Healthcare (RHCGF)
is a Sell
Is Ryman Healthcare a Buy or a Sell?
-
Ryman Healthcare stock is rated a Sell
The current Ryman Healthcare [RHCGF] share price is $2.61. The Score for RHCGF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.